Cost Effective Developments of Biologics: Early Stages of Development & Precise Viscosity Measurements with m-VROC®
In a recent article," The Importance of the Concentration—Temperature—Viscosity Relationship for the Development of Biologics," by Thomas Palm, Erinc Sahin, Rajesh Gandhi, and Mehrnaz Khossravi, stressed the importance of accurate viscosity measurement of biologics as a function of temperature and concentration.
Concentration and temperature variations can have a significant impact on the viscosity when concentration of monoclonal antibody are formulated at 100 mg/ml or higher for less-frequent dosing injection.
Through this study, it was advised that, “to successfully manufacture high-concentration parenterals, manufacturers must understand the concentration-temperature-viscosity profile of their drug products. The profile can be determined with little effort and material using temperature controlled microviscometer."
In this article, the viscosity of high‑concentration MAb drug product, with a specification for protein concentrations and at temperatures between 5 °C and 25 °C, was measured using a temperature‑controlled, m-VROC®.
m-VROC, with a wide viscosity range (from 0.2 ~ 100,000 mPa-s) and controlled temperature capabilities(4 ~ 70°C), enables accurate viscosity measurements required to monitor and help researchers understand their high concentrated protein solutions.
Palm, Thomas, Sahin, Erinc, Gandhi, Rajesh, and Khossravi, Mehmaz. "The Importance of the Concentration-Temperature-Viscosity Relationship for the Development of Biologics.” BioProcess Technical. BioProcess International., March. 2015. Web. 23 March 2015.